跳至主要内容
临床试验/NCT07052292
NCT07052292已完成不适用

DuraTouch® - Post-Market Clinical Follow-up (PMCF) Study in a Real-world Setting

Novo Nordisk A/S11 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2025年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
128
试验地点
11
主要终点
Participant rating the ease of use, convenience and satisfaction with the device

研究概览

简要总结

This study looks at overall impact of the use of DuraTouch® in terms of ease, convenience to use and satisfaction in participants with either type 1 or type 2 diabetes.The study will last for about 12 weeks.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •The decision to initiate treatment with DuraTouch® has been made by the participant/legally acceptable representative (LAR) and the treating physician before and independently from the decision to include the participant in this study.
  • •All needed signed consent(s) are obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).

排除标准

  • •Previous participation in this study. Participation is defined as having given informed consent in this study.
  • •Mental incapacity (when no caregiver and LAR are assigned to the patient), unwillingness or language barriers precluding adequate understanding or cooperation.

研究组 & 干预措施

DuraTouch® (Insulin injection)

Participants will subcutaneously inject the insulin prescribed by the doctor using DuraTouch® according to routine clinical practice at the discretion of the treating physician.

干预措施: DuraTouch® (Device)

结局指标

主要结局

Participant rating the ease of use, convenience and satisfaction with the device

时间窗: At week 12

Rating score on a 5-point Likert-type response scale. 1=Not at all easy/convenient/satisfied, 5=Extremely easy/convenient/satisfied.

次要结局

  • Participant rating the ease of preparing the device for use and ease of injection(At week 12)
  • Participant rating the confidence of using the device correctly and confidence in the device delivering the correct full dose(At week 12)
  • Participant rating ease to learn how to use the device(At week 12)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验

User Experience With DuraTouch® in Patients With... | 临床试验